Senior Policy and Advocacy Director; Respiratory and Immunology @ (November 2022 - June 2025)
Global Policy and Advocacy Director, Respiratory @ (February 2019 - November 2022)
Director, Global Public Health @ (September 2018 - February 2019)
Director Global Strategic Projects UNAIDS 90-90-90 @ (May 2016 - September 2018)
EU Policy, Community and Advocacy Lead @ (February 2013 - May 2016)
Medical Science Liaison @ (March 2008 - February 2013)
Brand Manager - market development Neurology @ (May 2005 - December 2006)
Neurology Nurse Advisor @ GSK (January 2003 - May 2005)
Parkinson's Disease Nurse Specialist @ Kings College Hospital (August 2000 - January 2003)
Anna Lawson Education
St Bartholomews' School of Nursing and Midwifery 1990-1993
Anna Lawson Skills
Advisory Boards
Chronic Respiratory Diseases
Clinical Development
Clinical Research
Clinical Trials
Health Sciences
Healthcare
Infectious Diseases
Market Access
Medical Affairs
Medical Education
Neurology
Pharmaceutical Industry
Project Management
Public Health
Rare Diseases
Chemical Engineering
Anna Lawson Summary
Anna Lawson, based in Cambridge, GB, is currently a Senior Director, Rare Disease Policy and Advocacy; at AstraZeneca. Anna Lawson brings experience from previous roles at AstraZeneca and ViiV Healthcare. Anna Lawson holds a 1990 - 1993 St Bartholomews' School of Nursing and Midwifery. With a robust skill set that includes Advisory Boards, Chronic Respiratory Diseases, Clinical Development, Clinical Research, Clinical Trials and more. Anna Lawson has 3 emails on RocketReach.
Looking for a different Anna Lawson?
Find contact details for 700 million professionals.